Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Pharmacological Research|June 29, 2014
Critical role of large-conductance calcium- and voltage-activated potassium channels in leptin-induced neuroprotection of N-methyl-d-aspartate-exposed cortical neuronsMaria Mancini, Maria Virginia Soldovieri, Guido Gessner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2017
Intermittent theta-burst stimulation rescues dopamine-dependent corticostriatal synaptic plasticity and motor behavior in experimental parkinsonism: Possible role of glial activityFabrizio Cacace, Desirèe Mineo, Maria Teresa Viscomi, et al.
Scientific Reports|July 21, 2015
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashionVeronica Ghiglieri, Francesco Napolitano, Barbara Pelosi, et al.
Neurobiology of Disease|December 8, 2015
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanismsVeronica Ghiglieri, Desiree Mineo, Anna Vannelli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2010
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of boneLuigi Gennari, Fernando Gianfrancesco, Marco Di Stefano, et al.
Molecular Neurobiology|May 12, 2026
Cell Cycle Dysfunction and Metabolic Alterations Consistent With Pathological Tau in Progressive Supranuclear Palsy Derived FibroblastsRoberta De Mori, Francesca Ciaiola, Valentina Nesci, et al.
Journal of Neurology|August 13, 2025
CSF phospho-tau levels at Parkinson's disease onset predict the risk for development of motor complicationsJacopo Bissacco, Giulia Di Lazzaro, Roberta Bovenzi, et al.
Journal of Neuroimmunology|April 9, 2025
Sex-specific immune-biological profiles in Parkinson's diseaseRoberta Bovenzi, Matteo Conti, Clara Simonetta, et al.
Neuromuscular Disorders : NMD|March 8, 2021
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trialRichard S Finkel, Erika Finanger, Krista Vandenborne, et al.
Lung Cancer (Amsterdam, Netherlands)|March 23, 2024
Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicineJosephine A Taverna, Chia-Nung Hung, Madison Williams, et al.
Pageof 8